AUS
NZ
UK
CA
USA
IND
Healthcare
BlinkLab (ASX: BB1) Partners with INTER-PSY to Advance Autism Diagnosis
September 12, 2024 06:33 PM AEST| By Team Kalkine MediaBlinkLab has embarked on a significant partnership with INTER-PSY to advance the capabilities of its autism diagnostic platform. This collaboration aims to optimize BlinkLab's experimental and AI algorithms, facilitating the path to regulatory approv...
CSL Ltd (ASX: CSL) Shares Up 4% in 2024: Should They Be on Your Radar?
September 12, 2024 02:42 PM AEST| By Team Kalkine MediaCSL Ltd has seen its share price climb 4.0% since the beginning of 2024. As an,ASX healthcare stock,, this rise reflects the company’s ongoing commitment to developing innovative medicines that address critical health needs and contribute to improved...
GTI extends uranium mineralisation at Lo Hema through development drilling
September 12, 2024 01:18 PM AEST| By Team Kalkine MediaClarity Pharmaceuticals Ltd (ASX:CU6) has announced progress in its ongoing SECuRE trial, with positive safety results from the latest stage. The trial focuses on prostate cancer treatment using Cu-SAR-bisPSMA, targeting prostate-specific membrane an...
Dimerix Begins Phase 3 Recruitment for Kidney Disease Study in Mexico
September 12, 2024 11:15 AM AEST| By Team Kalkine MediaDimerix Limited (ASX:DXB) has announced the commencement of patient recruitment for its ‘ACTION3’ Phase 3 clinical trial. This significant milestone involves enrolling adolescent patients aged 12 to 17 with kidney disease in Mexico. The selection of...
Pro Medicus Limited (ASX: PME): Why the Surge in Share Price?
September 10, 2024 02:13 PM AEST| By Team Kalkine MediaThe Pro Medicus Limited,(ASX: PME),share price has experienced a remarkable 63.6% increase since the beginning of 2024. This impressive rise in value highlights the growing interest in PME shares and raises the question of what is driving this surge....
Noxopharm Obtains $1.8 Million in Funding Ahead of R&D Rebate
September 09, 2024 02:19 PM AEST| By Team Kalkine MediaNoxopharm Ltd,(ASX:NOX),has secured $1.8 million in advanced funding through a secured loan agreement with Endpoints Capital Pty Ltd, a specialist in R&D finance for the life sciences sector. This loan is backed by an anticipated rebate from the Aust...
CSL Ltd and Pro Medicus Limited: Current Performance and Key Insights
September 09, 2024 01:53 PM AEST| By Team Kalkine MediaAs the year progresses, CSL Ltd and Pro Medicus Limited are making significant strides in their respective sectors. CSL Ltd, an,ASX healthcare stock,, has experienced a notable rise in its share price, reflecting its robust position in the biotechnol...
Exploring the Latest Developments in RMD Shares
September 06, 2024 04:06 PM AEST| By Team Kalkine MediaResMed CDI has been on a remarkable upward trajectory in 2024, with its share price surging 42.6% since the start of the year. Investors are taking a keen interest in RMD shares,(ASX:RMD),, and several factors are contributing to this impressive perf...
Breakthroughs in Coronary Disease Indicate Potential Future Reduction in Deaths
September 06, 2024 02:47 PM AEST| By Team Kalkine MediaCoronary disease remains the leading cause of death in Australia, accounting for about 24% of all fatalities. While the World Health Organisation estimates that approximately 17.9 million people worldwide succumb to coronary diseases annually, recent...
Orthocell Products Enter Canadian Market with Initial Sale via Partner BioHorizons
September 06, 2024 02:21 PM AEST| By Team Kalkine MediaOrthocell Ltd,(ASX: OCC,), has advanced its global market expansion by making its debut in the Canadian biotech sector with the first sale of its products through distribution partner BioHorizons. This milestone marks a significant step in Orthocell’...
Immuron Receives Positive Feedback from US FDA Ahead of IMM-529 Investigational New Drug Application
September 06, 2024 02:20 PM AEST| By Team Kalkine MediaImmuron Ltd,(ASX:IMC),has received positive feedback from the United States Food and Drug Administration (FDA) regarding its IMM-529 product, aimed at preventing or treating Clostridioides difficile infection (CDI). This feedback follows a pre-IND (I...
Biotron Ltd (ASX:BIT) Faces Backlash Over Disappointing COVID Drug Trial Results
September 06, 2024 01:34 PM AEST| By Team Kalkine MediaBiotron Ltd,(ASX:BIT),is under scrutiny following the results of its latest trial for its COVID-19 drug, BIT225-012. The trial results, which were eagerly anticipated, have not met the expectations of shareholders and have been met with frustration o...
Pacific Smiles CEO Andrew Vidler Steps Down Amid Company Transition
September 06, 2024 11:53 AM AEST| By Team Kalkine MediaPacific Smiles Group Ltd,(ASX:PSQ),, a prominent player in the dental industry, has announced the resignation of its Chief Executive Officer, Andrew Vidler. The company revealed that Vidler will fulfill a six-month notice period before officially ste...
Orthocell Expands Global Reach with Collagen-Based Dental Bone Repair Product in Canada
September 06, 2024 10:39 AM AEST| By Team Kalkine MediaOrthocell (ASX:OCC) has achieved another milestone with its collagen-based bone repair product, Striate+, as the company confirms initial sales in Canada. This marks a significant step in Orthocell’s ongoing global expansion, following successful mar...
CLEO Diagnostics Launches Major Ovarian Cancer Blood Test Trials in the U.S.
September 06, 2024 10:02 AM AEST| By Team Kalkine MediaCLEO Diagnostics (ASX:COV) has embarked on significant U.S.-based trials aimed at assessing the reliability and effectiveness of its ovarian cancer-detecting blood tests. The tests are intended to identify ovarian cancer in its early stages, marking...
Race Oncology Finalizes Board Overhaul to Advance Next Growth Phase
September 04, 2024 05:21 PM AEST| By Team Kalkine MediaRace Oncology Ltd,(ASX: RAC),has reached a significant milestone in its strategic development, completing a comprehensive board renewal process aimed at strengthening its leadership team for future growth. The company has appointed Dr. Peter Smith as...
Lumos Diagnostics Adds Tenmile Ventures as New Shareholder
September 04, 2024 05:19 PM AEST| By Team Kalkine MediaLumos Diagnostics Holdings Ltd,(ASX:LDX),is raising A$10 million through a pro rata accelerated non-renounceable entitlement offer, with the retail component underwritten up to approximately A$6 million. The offer has generated significant interest,...
The Transformative Impact of Regenerative Medicine on Healthcare
September 04, 2024 05:15 PM AEST| By Team Kalkine MediaRegenerative medicine is revolutionizing health care by focusing on repairing, replacing, or regenerating damaged or diseased cells, tissues, or organs to restore normal function. This emerging field integrates biology, engineering, and clinical prac...
Lumos Diagnostics Gains Twiggy Forrest as Key Investor in $10M Raise
September 04, 2024 05:12 PM AEST| By Team Kalkine MediaEmerging companies Lumos Diagnostics, Memphasys, and Vitura Health are making notable strides in their respective sectors. From advancing diagnostic technologies to revolutionizing fertility solutions and expanding telehealth services, these,ASX heal...
Lumos Diagnostics Wins Twiggy Forrest as Major Investor
September 04, 2024 12:56 PM AEST| By Team Kalkine MediaIn today's market updates, Lumos Diagnostics aims to raise $10 million to advance its diagnostic technology, while,ASX healthcare stock,Memphasys ventures into the equine fertility sector with its innovative sperm-selection device. Vitura Health also...
Advertise your brand on Kalkine Media